24.2 C
Accra
Tuesday, August 5, 2025
WorldBharat Biotech: India launches its first nasal COVID vaccine

Date:

Bharat Biotech: India launches its first nasal COVID vaccine

The first nasal Covid vaccine has received approval in India.


iNCOVACC, a product of Bharat Biotech, is a nasal drop that triggers an immune response in the tissues lining the nasal cavity.

A spray-based Covid vaccine for inhalation was authorised in China in September 2022.

In the lining of the nose and upper airways, where Covid typically enters the body, nasal vaccines, according to scientists, may provide supplemental immunity.

Nasal spray vaccines have also been the subject of investigation by research teams in the US and the UK.

In November, India’s drug regulator approved the use of iNCOVACC as a heterologous booster dose – a booster for people who had previously received two doses of Covishied or Covaxin, the two main Indian vaccines – in emergency situations among adults.

In December, it was approved by the drug regulator as a primary vaccine and as a subsequent booster shot in adults.

The vaccine will cost 800 rupees ($10; £8) per dose in private hospitals and 325 rupees per dose in government hospitals and can be booked on the government’s online platform. Two doses are to be taken 28 days apart.

iNCOVACC uses a adenovirus as a carrier for the genetic code that teaches the body how to fight the infection. Adenoviruses used in the vaccines are harmless transporters which have been modified so they cannot replicate or cause infection.

Dr Krishna Ella, chairman of Bharat Biotech, told ANI news agency that the vaccine was “easy to deliver” as it didn’t need a syringe or needle, and that it produced a broader immune response as compared to injectable Covid vaccines.

India has administered over two billion Covid jabs so far. More than 70% of the Indian population has taken at least two doses, according to the federal health ministry.

In January 2022, India began giving boosters to healthcare and frontline workers, and those above 60 years with comorbidities. It was later expanded to all adults. However, the pace of booster doses administrated has been slow.

[forminator_poll id="710479"]

Latest stories

“Don’t make me and Stonebwoy fight ooo”- Samini warn netizens

Veteran dancehall musician, Samini has warned netizens to resist...

Kanye West’s Heil Hitler song bans him from entering Australia

US rapper Kanye West has been banned from entering...

Agradaa describes moment shared with President Mahama heavenly – Agradaa

Evangelist Patricia Asiedua, popularly known as Agradaa, shared a...

Dada Joe Remix extradited to face romance scam charges in USA

Ghana’s nightlife mogul and alleged crypto kingpin, Nana Kojo...

Govt launches 24-Hour Economy policy today

The government's flagship, 24-Hour Economy Policy, will be launched...

GRA sets July 16 for GHS1 fuel levy implementation

The implementation of the new GHS1 Energy Sector Shortfall...

Related stories

US travel ban against Togo, Libya, others takes effect today

Effective today, Monday, June 9, nationals of twelve countries...

Pakistan: Police in search of over 200 inmates following earth tremor

Over 200 inmates are currently on the run after...

Pope Leo XIV shares canonical acceptance

Cardinal Robert Francis Prevost has officially accepted his election...

Profile of the new Pope – Cardinal Robert Francis Prevost

"Peace be with all of you!" - the first...

Cardinal Robert Francis Prevost named as the 267th Pope, takes the name Pope Leo XIV

Cardinal Robert Francis Prevost has been elected as the...

Black smoke signals end of first day of conclave to elect new pope

A thick column of black smoke rising from the...

Siemens exec and his family involved in fatal Hudson helicopter crash

Tragedy struck New York City on Thursday when a...